Guilherme Hirassawa Sacillotto

Guilherme Hirassawa Sacillotto

Auto-generated profile, based on publicly available information

Guilherme Hirassawa Sacillotto

Residência em Medicina Intensiva, Hospital de Base, Faculdade de Medicina de São José do Rio Preto - FAMERP - São José do Rio Preto (SP), Brasil

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2019 in Journal of Clinical Virology
Verified
Journal Article
Closed access
SLSuzana Margareth Lobo
Suzana Margareth Lobo
AWAripuana Watanabe
Aripuana Watanabe
MSMaria Lúcia Machado Salomão
Maria Lúcia Machado Salomão
FQFlavia Queiroz
Flavia Queiroz
JGJoelma Villafanha Gandolfi
Joelma Villafanha Gandolfi
MNMauricio Nogueira
Mauricio Nogueira

10 November 2022 in Jornal Brasileiro de Pneumologia
Verified
Journal Article
Open access
AOAna Beatriz Souza de Oliveira
Ana Beatriz Souza de Oliveira
GSGuilherme Hirassawa Sacillotto
Guilherme Hirassawa Sacillotto
MNManuela Francisco Balthazar Neves
Manuela Francisco Balthazar Neves
ASAndressa Hellen Nora da Silva
Andressa Hellen Nora da Silva
TMTamiris Adriane Moimaz
Tamiris Adriane Moimaz
SLSuzana Margareth Lobo
Suzana Margareth Lobo
Objective: To determine the prevalence, outcomes, and predictors of multidrug-resistant nosocomial lower respiratory tract infections (LRTI) in patients in an ICU. Methods: This was an observational cohort study involving patients with nosocomial LRTI (health care-associated pneumonia, hospital-acquired pneumonia, or ventilator-associated pneumonia). Data were prospectively collected between 2015 and 2019. The multidrug-resistant pathogens (MDRPs) identified in the isolates studied included resistant to extended-spectrum cephalosporin-resistant and carbapenem-resistant Acinetobacter baumannii, Klebsiella pneumoniae, and Pseudomonas aeruginosa, carbapenem-resistant Enterobacteriaceae, and methicillin-resistant Staphylococcus aureus at microbiological diagnosis. Results: During the study period, 267 patients in the ICU were diagnosed with LRTI, microbiological confirmation of LRTI having been obtained in 237. Of these, 146 (62%) had at least one MDRP isolate. Patients infected with MDRP were found to have poorer outcomes than patients infected with susceptible strains, such as prolonged mechanical ventilation (18.0 days vs. 12.0 days; p < 0.001), prolonged ICU length of stay (23.0 days vs.16.0 days; p < 0.001), and higher mortality (73% vs. 53%; p < 0.001) when compared with patients infected with susceptible strains. Hospital length of stay = 5 days (OR = 3.20; 95% CI: 1.39-7.39; p = 0.005) and prolonged use vasoactive drugs (OR = 3.15; 95% CI: 1.42-7.01; p = 0.004) were independent predictors of LRTI caused by MDRPs (LRTI-MDRP). The presence of LRTI-MDRP was found to be an independent predictor of death (OR = 2.311; 95% CI: 1.091-4.894; p = 0.028). Conclusions: Prolonged use of vasoactive drugs and prolonged hospital length of stay were independent predictors of LRTI-MDRP in this population of critically ill patients with very poor outcomes.